返回 Agenda
Leveraging Pharma Intelligence Data and Statistical Modeling to Inform Project Strategies
Session Chair(s)
Mark Kryah, PMP
Executive Director, Program Team Leader, Program and Portfolio Management
Ultragenyx Pharmaceutical Inc., United States
This session will explore use of external intelligence data sources in advanced statistical modeling to inform program strategies and clinical designs. Case studies will be shared.
Learning Objective : Describe various external data sources that can be used for statistical modeling; Identify how to use statistical modeling approaches leveraging this external data; Discuss how statistical modeling can inform and influence project strategies and clinical designs.
Speaker(s)
Informing Drug Development via Landscape Modeling Using Pharma Intelligence Data
Zhaoling Meng, PHD, MS
Sanofi, United States
AVP, Global Head of Clinical Modeling and Evidence Integration
Application of Advanced Modeling on Development Programs
Shameer Khader, PHD, MPH
AstraZeneca, United States
Senior Director, Data Science and Artificial Intelligence